CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows used in operating activities:
Net loss	$ (55,909)	$ (15,776)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	147	209
Amortization of intangibles and interest accretion of contingent consideration	40,612	3,951
Amortization of deferred financing costs	1,393	777
Interest accretion of notes receivable	(95)	(171)
Deferred income tax benefit	(7,424)	(5,999)
Loss on disposal of equipment	0	153
Stock compensation expense	3,085	2,519
Fair market value change in derivative liability	(8,703)	0
Accretion of debt discount	616	0
Issuance of stock for inducement	19,500	0
Expense from stock options issued in exchange for services	0	119
Loss on sale of PML (including impairment charge)	0	6,672
Cancellation of ParaPRO stock options in connection with termination of contract	0	(1,294)
(Increase) decrease in operating assets
Accounts receivable	(2,268)	2,924
Income taxes	(457)	(4,030)
Inventory	1,414	696
Prepaid expenses and other assets	(1,644)	36
Increase (decrease) in operating liabilities
Accounts payable and accrued expenses	(38)	(982)
Accrued allowances	(406)	0
Interest payable	2,588	0
Other liabilities	(2,334)	0
Net cash used in operating activities	(9,923)	(10,196)
Cash flows from investing activities:
Proceeds from sale of PML	0	1,177
Acquisition of Zohydro ER	(80,927)	0
Proceeds from sale of property and equipment	0	41
Purchase of equipment	(726)	(419)
Net cash (used in) provided by investing activities	(81,653)	799
Cash flows from financing activities:
Net proceeds from issuance of Convertible Notes	130,000	65,000
Net drawdowns (payments) on revolving credit facility	596	(3,731)
Payments for financing costs	(5,045)	(6,231)
Payment of consent fee	(2,150)	0
Payments on mortgages and capital leases	(13)	(46)
Payments on contracts payable	0	(1,500)
Proceeds from issuance of common stock, net of tax	285	1,949
Stock issuance costs	(9)	0
Tax benefit on stock-based awards	0	(147)
Shares withheld for the payment of taxes	(112)	(753)
Net cash provided by financing activities	123,552	54,541
Net increase in cash and cash equivalents	31,976	45,144
Cash and cash equivalents, beginning of period	34,855	15,647
Cash and cash equivalents, end of period	$ 66,831	$ 60,791